Prof. Hülya Hamzaoğlu is a distinguished gastroenterologist with a strong academic and clinical background. She earned her professorship from Marmara University Faculty of Medicine in 2004 and has since combined expert clinical practice with leadership in professional organizations. Since 2010 she has been affiliated with Acıbadem Health Group, contributing to high-quality patient care and teaching. She is an active member of the Turkish Gastroenterology Association and the Turkish Association for Liver Research. She also leads the Inflammatory Bowel Diseases Association as its President, where she focuses on advancing research, education, and patient care for inflammatory bowel conditions. Areas of expertise: gastroenterology, inflammatory bowel disease, liver research, clinical leadership, medical education.
Education
- 2004 Marmara University Faculty of Medicine / Professor
- 1996 Turkey High Specialization Training and Research Hospital Gastroenterology
- 1993 Taksim Training and Research Hospital Internal Medicine
- 1988 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2010 Acibadem Health Group
- 2004 – 2005 Beth Israel Deaconess Medical Center, Harvard Medical School, Boston-U.S.A. Inflammatory Bowel Clinic (6 months)
- 2004 Professor, Department of Gastroenterology, Marmara University Faculty of Medicine
- 1997 Giessen Universitat, Medizische Klinik, Giessen-Germany (1 month)
- 1993 – 1995 Clinic of Gastroenterology, Turkey High Specialization Training and Research Hospital
- 1993 Beth Israel Hospital, Harvard Medical School Boston-USA, Gastroenterology Division
- 1989 – 1993 Taksim Training and Research Hospital Internal Medicine Residency Training
Memberships
- Turkish Gastroenterology Association
- Inflammatory Bowel Diseases Association (President)
- Turkish Association for Liver Research
Publications
- Safety of infliximab in Crohn’s Disease: A large single center experience. Inflam Bowel Dis.
2010 Apr 9. Pub Med PMID: 2088473 Hamzaoglu H, Cooper J, Alsahli M, Falchnuk KR, Peppercorn MA, Farrell RJ. - What is the most accurate method for the diagnosis of intestinal tuberculosis?
Turk J Gastroenterol. 2010 Mar 21(1):91-6 Yonal 0, Hamzaoglu H.
Dig Dis Sci. 2008 Feb;53(2):481-5. Atug O,Hamzaoglu H, Tahan V, Alican I, Kurtkaya E, Elbuken E, Ozdogan O, Tozun N.- Distribution of common CARD15 variants in patients with sporadic Crohn’s disease:cases from Turkey.
Dig. Dis. Sci. 2006 Apr;51 (4):706 10. Over Hamzaoglu H, Ture F, Gul A, Tozun N, Saruhan-Direskeneli G. - Prothrombotic gene mutations and Crohn’s disease; is there any association?
Hepatogastroenterology. 2005 Sep-Oct;52(65): 1467 -9. Over Hamzaoglu H, Abaci N, Ture F, Alkim C, Tezel N, Avsar E, Tozun N. - Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.
World J Gastroenterol 2003; 9 :2325-27 Tahan V, Avsar E, Karaca C, Uslu E, Aydm S, Uzun H, Hamzaoglu HO, Besisik F, Kalayci C, Otken A, Tozun N. - Does Becaplermin (Platelet- Derived Growth Factor-BB) reverse detrimental effects of ischemia on colonic anastomosis.
Dis Colon Rectum 2003;46:516-520 Sarıbeyoglu K, Baca B, Hamzaoglu i, Pekmezci S, Karahasanoglu T, Hamzaoglu H. - Clinical outcome of Crohn’s disease treated with Infliximab.
Hepato-Gastroenterology 2003; 50 :952 -56 Arslan S, Kav T, Besisik F, Kaymakoglu S, Pmarbasi B, TOzun N, Over Hamzaoglu H, Duman D, Ulker A, Parlak E, Palabiyikoglu E, Dokmeci A. - Transrectal ultrasound in the diagnosis and management of inflammatory bowel disease.
Endoscopy 1999;31:152-156 Dagli U, Over H, Tezel A, Ulker A, Temucin G. - Thrombophilia and inflammatory bowel disease; Does FV mutation have a role.
Eur J Gastroenterol Hepatol 1998; 10:827 -830 Hamzaoglu HO, Ulgen SK, Tuglular TF, Tezel A, Avsar E.Geyik G, Basgul S, Saydam N, Kalayci C, Ulusoy NB, Tozun N. - Endoscopic balloon dilation of strictures complicating solitary rectal ulcer syndrome.
Endoscopy 1997;29:427 -429 Over H, Ulker A, Baysal C, Dagli U. - Toothpick impaction; treatment by colonoscopy.
Endoscopy 1997; 29:S60-61 Over HH, TOzun N, Avsar E. - The role of reactive oxygen metabolites in ulcerative colitis.
Inflamm bowel dis 1997;3:260-64 Dagli U, Ballk M, Yucel D, Ulker A, Over H, Saydam G, Sahin B.
